Risk Adapted Treatment of Unilateral Favorable Histology Wilms Tumors (FHWT)

Sponsor:

COG

Sponsor Study ID:

AREN2231

CTO #:

104230

NCT Number:

NCT06401330

Phase:

III

Protocol Type:

Treatment

Age Group:

Children

Disease Sites:

Kidney

Study Objectives:

Event-free survival (EFS) [Time Frame: Up to 4 years from study entry] Kaplan-Meier method will be used to estimate 4-year EFS, defined as the time from randomization or first diagnostic nephrectomy or biopsy until relapse or disease progression, secondary malignancy, or death.

eConsent:

Not available

Study Documents:

Open Study Documents
(MUSC NetID required for document access)